Adjuvant trials suggest changes to non–small cell lung cancer treatment paradigm
Saved in:
Published in | Cancer Vol. 127; no. 22; pp. 4121 - 4122 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
15.11.2021
|
Online Access | Get full text |
Cover
Loading…
Author | Hay, Ashley |
---|---|
Author_xml | – sequence: 1 givenname: Ashley surname: Hay fullname: Hay, Ashley |
BookMark | eNotkE1OwzAQRi1UJNrChhP4Ailjj-skyyriT6pAqrpgF00cJ6RK3CpOQN1xB27ISXALm5nvW8wb6c3YxO2dZexWwEIAyDvjTL9ATGO4YFMBaRyBUHLCpgCQREuFb1ds5v0u1Fgucco2q3I3fpAb-NA31Hrux7q2fuDmnVwIfNjz8OPn69t31Lbc2DDa0dXckDO2D2eWhs4GwIF6Kpu6u2aXVSDZm_89Z9uH-232FK1fH5-z1Toa4wQi0mlSaBOXoLRIrFJJUhEikixQGkNpClKgqRSp0pLWUqdWky0QYrRQFjhn4g_72bT2mB_6pqP-mAvITybyk4n8bCLPXrLNOeEvFbBX7g |
ContentType | Journal Article |
Copyright | 2021 American Cancer Society |
Copyright_xml | – notice: 2021 American Cancer Society |
DOI | 10.1002/cncr.33970 |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-0142 |
EndPage | 4122 |
ExternalDocumentID | CNCR33970 |
Genre | article |
GroupedDBID | --- -~X .3N .GA 05W 0R~ 10A 1CY 1L6 1OC 24P 29B 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AARRQ AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABHFT ABIJN ABIVO ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEIGN AEIMD AENEX AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AIACR AIAGR AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EMOBN EX3 F00 F01 F04 F5P FD6 FUBAC G-S G.N GNP GODZA GX1 H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ KZ1 L7B LATKE LAW LC2 LC3 LH4 LITHE LMP LOXES LP6 LP7 LSO LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SJN SUPJJ TEORI UDS UHB V2E V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WJL WOHZO WQJ WRC WVDHM WXI WXSBR XG1 XPP XV2 Z0Y ZGI ZZTAW ~IA ~WT |
ID | FETCH-LOGICAL-u780-a698b6c7d04618e4488fa333a2b32cca990213cf4a4dea66269e6aeb3073e0db3 |
IEDL.DBID | DR2 |
ISSN | 0008-543X |
IngestDate | Sat Aug 24 00:59:27 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 22 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-u780-a698b6c7d04618e4488fa333a2b32cca990213cf4a4dea66269e6aeb3073e0db3 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.33970 |
PageCount | 2 |
ParticipantIDs | wiley_primary_10_1002_cncr_33970_CNCR33970 |
PublicationCentury | 2000 |
PublicationDate | November 15, 2021 |
PublicationDateYYYYMMDD | 2021-11-15 |
PublicationDate_xml | – month: 11 year: 2021 text: November 15, 2021 day: 15 |
PublicationDecade | 2020 |
PublicationTitle | Cancer |
PublicationYear | 2021 |
References | 2021; 39 |
References_xml | – volume: 39 year: 2021 article-title: OlympiA: a phase III, multicenter, randomized, placebo‐controlled trial of adjuvant olaparib after (neo) adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high‐risk HER2‐negative early breast cancer publication-title: J Clin Oncol – volume: 39 year: 2021 article-title: Pembrolizumab versus placebo as post‐nephrectomy adjuvant therapy for patients with renal cell carcinoma: randomized, double‐blind, phase III KEYNOTE‐564 study publication-title: J Clin Oncol – volume: 39 year: 2021 article-title: Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: the randomized phase III OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274) publication-title: J Clin Oncol – volume: 39 year: 2021 article-title: IMpower010: primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB‐IIIA non–small cell lung cancer (NSCLC) publication-title: J Clin Oncol |
SSID | ssj0007253 |
Score | 2.4230664 |
SourceID | wiley |
SourceType | Publisher |
StartPage | 4121 |
Title | Adjuvant trials suggest changes to non–small cell lung cancer treatment paradigm |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.33970 |
Volume | 127 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV29TsMwELaqDoiFf8S_PDAhuU3sOLYllqpQVUjtUBWpC4rs2KmANkVNsjDxDrwhT4KdpK1gg82DLZ3O57v77LvPAFwrI5nQiY-YxxgKBEkQp1ojkdDEp9oTmLoG58Ew7D8GDxM6aYDbVS9MxQ-xvnBzJ6P01-6AS5W1N6ShcRovW8SGUwfYfcJcPd_daMMdxXBNQelxRAMyWXOT4vZm6c-UtIwpvV3wtJKmKiV5bRW5asXvv4ga_yvuHtipk03YqaxjHzRMegC2BvVz-iEYdfRLYVPpHJafd2QwK6buvQlW7cAZzBcwXaRfH5_ZXM5m0N3yw5l1DzB2xrKE6zJ16CjE9fN0fgTGvftxt4_qTxZQwbiHZCi4CmOmHfE6Nxas8UQSQiRWBNvdtcEK-yROAhloI0MLf4QJpUXg1jUYTytyDJpWEHMCoMahnei2mJmAMqW4tFjF2ojQQsvYOwU3pYKit4pHI6oYk3HkVBOVqom6w-6oHJ39ZfI52Mau1MRV59EL0MyXhbm0uUKurkqb-AYKXr2Z |
link.rule.ids | 314,780,784,1375,27924,27925,46294,46718 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV27TsMwFLVQkYCFN-KNByYkt6kdx_FYFaoCbYeqSN0iO3YqoE1RkyxM_AN_yJdgO1Er2GDL4EjW9X373GMArqUWjKukiZjHGPI5SVBIlUI8oUmTKo9jagec-4Og--Q_jOm4wubYWZiSH2LZcLOW4fy1NXDbkG6sWEPjNF7UiYmnpmJfN_betIiu2-GKPYrhioTSCxH1yXjJToobq39_JqUuqnR2yqdTM0dGaMEkr_Uil_X4_RdV4783vAu2q3wTtkoF2QNrOt0HG_3qRv0ADFvqpTDZdA7d-x0ZzIqJvXKC5URwBvM5TOfp18dnNhPTKbSNfjg1HgLGVl8WcIlUh5ZFXD1PZodg1LkbtbuoemcBFSz0kAh4KIOYKcu9HmpTr4WJIIQILAk2B2ziFW6SOPGFr7QITAXEdSBMEW68g_aUJEegZjaijwFUODAL7Skz7VMmZShMuWLUhCuuROydgBsnoeitpNKIStJkHFnRRE40UXvQHrqv078svgKb3VG_F_XuB49nYAtb5IkF69FzUMsXhb4wqUMuL52CfAP8K8G6 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ07T8MwEICtCqSKhTfijQcmJLepHcexxFK1VOXRClVF6oIiO3YqoE2rJlmY-A_8Q34JdtKHYIMtgyOdzmffnX33GYBLqQXjKqoh5jCGXE4i5FOlEI9oVKPK4ZjaBudO12s_uXcDOiiB60UvTMGHWB642ZWR79d2gU9VVF1BQ8M4nFWIcacmYV93PcwtOb_ZW8GjGJ4zKB0fUZcMlnBSXF39-zMmzZ1Kaws8L8QpakneKlkqK-H7L1Ljf-XdBpvzaBPWC_PYASUd74JyZ36fvgd6dfWamVg6hfnrHQlMsqG9cIJFP3AC0wmMJ_HXx2cyFqMRtMf8cGT2Bxhaa5nBZZ06tAxx9TIc74N-66bfaKP5KwsoY76DhMd96YVMWfK6r0225keCECKwJNhMr_FWuEbCyBWu0sIz-Q_XnjApuNkbtKMkOQBrRhB9CKDCnhlo55hplzIpfWGSFWMkXHElQucIXOUKCqYFSCMokMk4sKoJctUEjW6jl38d_2XwBSg_NlvBw233_gRsYFt2Yiv16ClYS2eZPjNxQyrPc_P4BveUwGk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adjuvant+trials+suggest+changes+to+non%E2%80%93small+cell+lung+cancer+treatment+paradigm&rft.jtitle=Cancer&rft.au=Hay%2C+Ashley&rft.date=2021-11-15&rft.issn=0008-543X&rft.eissn=1097-0142&rft.volume=127&rft.issue=22&rft.spage=4121&rft.epage=4122&rft_id=info:doi/10.1002%2Fcncr.33970&rft.externalDBID=10.1002%252Fcncr.33970&rft.externalDocID=CNCR33970 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon |